-
-
-
-
-
-
-
Jefferies Reiterates Buy Rating on Novavax (NVAX): "capital-light adjuvant platform with improving line-of-sight"
-
-
-
-
-
-
-
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
-
-
-
-
-
-
-
Biotech stocks Q1 earnings review
-
-
-
-
-
-
-
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
-
-
-
-
-
-
-
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
-
-
-
-
-
-
-
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Stock Market Today: Dow ends higher on tech gains as earnings season to heat up
-
1,215,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

